SOPH
SOPHiA GENETICS S.A. NASDAQ$5.29
Mkt Cap $379.1M
52w Low $2.59
86.8% of range
52w High $5.70
50d MA $4.82
200d MA $4.40
P/E (TTM)
-4.5x
EV/EBITDA
-5.0x
P/B
7.6x
Debt/Equity
1.3x
ROE
—
P/FCF
-8.2x
RSI (14)
—
ATR (14)
—
Beta
1.04
50d MA
$4.82
200d MA
$4.40
Avg Volume
128.7K
About
SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory, and biopharma worldwide. SOPHiA GENETICS SA was inc…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 3, 2026 | BMO | -0.24 | -0.28 | -17.9% | 4.10 | +0.5% | +2.9% | +2.9% | +5.6% | +6.1% | +8.8% | — |
| Nov 4, 2025 | BMO | -0.20 | -0.30 | -50.0% | 4.68 | -3.0% | -3.4% | -3.4% | +1.3% | -6.6% | -7.1% | — |
| Aug 5, 2025 | BMO | -0.21 | 0.33 | +257.1% | 3.42 | -7.9% | -7.9% | -7.9% | -6.4% | -7.0% | -12.0% | — |
| May 6, 2025 | BMO | -0.21 | -0.26 | -23.8% | 3.00 | +3.0% | +0.0% | +0.0% | -0.3% | -2.3% | +6.3% | — |
| Mar 4, 2025 | BMO | -0.23 | -0.23 | +0.0% | 3.10 | +5.5% | +0.3% | +0.3% | +0.3% | +4.5% | +3.5% | — |
| Nov 5, 2024 | BMO | -0.24 | -0.28 | -16.7% | 3.75 | -9.3% | -9.3% | -9.3% | -9.3% | -6.1% | +1.1% | — |
| Aug 6, 2024 | BMO | -0.28 | -0.23 | +17.9% | 4.06 | +0.0% | -10.1% | -10.1% | -17.2% | -20.2% | -21.4% | — |
| May 7, 2024 | BMO | -0.25 | -0.21 | +16.0% | 4.97 | +1.6% | -7.4% | -7.4% | -3.0% | -5.6% | -7.8% | — |
| Mar 5, 2024 | BMO | -0.25 | -0.37 | -48.0% | 5.60 | -8.0% | -10.5% | -10.5% | -10.9% | -15.5% | -13.4% | — |
| Nov 7, 2023 | BMO | -0.32 | -0.21 | +34.4% | 3.91 | -4.1% | +0.0% | +0.0% | -0.8% | -13.0% | -17.6% | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 15 | BTIG | Maintains | Buy → Buy | — | $4.96 | $4.96 | +0.0% | +2.2% | +3.2% | +6.5% | +4.6% | +3.2% |
| Jan 26 | Guggenheim | Maintains | Buy → Buy | — | $5.36 | $5.36 | +0.0% | -0.7% | -2.1% | -2.1% | -3.5% | -2.1% |
| Nov 10 | BTIG | Maintains | Buy → Buy | — | $4.37 | $4.37 | +0.0% | -0.5% | +5.7% | -1.1% | +0.2% | -1.4% |
| Aug 7 | RBC Capital | Maintains | Outperform → Outperform | — | $4.06 | $4.06 | +0.0% | -10.1% | -17.2% | -20.2% | -21.4% | -16.5% |
| Mar 6 | BTIG | Maintains | Buy → Buy | — | $5.60 | $5.15 | -8.0% | -10.5% | -10.9% | -15.5% | -13.4% | -16.8% |
| Mar 6 | RBC Capital | Maintains | Outperform → Outperform | — | $5.60 | $5.15 | -8.0% | -10.5% | -10.9% | -15.5% | -13.4% | -16.8% |
| Jan 12 | RBC Capital | Maintains | Outperform → Outperform | — | $5.50 | $5.46 | -0.7% | -4.9% | -16.9% | -16.5% | -18.0% | -18.2% |
| May 10 | Credit Suisse | Maintains | Neutral → Neutral | — | $4.85 | $4.86 | +0.2% | -4.5% | -4.5% | -7.0% | -8.0% | -12.8% |
| May 10 | Morgan Stanley | Maintains | Overweight → Overweight | — | $4.85 | $4.86 | +0.2% | -4.5% | -4.5% | -7.0% | -8.0% | -12.8% |
| Mar 8 | Morgan Stanley | Maintains | Overweight → Overweight | — | $2.53 | $2.60 | +2.8% | +21.7% | +31.2% | +36.8% | +43.5% | +97.2% |
Data updated apr 27, 2026 2:27am
· Source: massive.com